Ethisterone raw material powder for pharmaceutical manufacture

• Post Date:

  Nov 23,2017

• Expiry Date:

  May 22,2018

• Detailed Description:

  Cas No. :434-03-7 Quantity: 0.1Kilograms
  Payment Method: TT,Western Union,Money gram
  Ethisterone
  
  English Synonyms: 4,17ALPHA-PREGNEN-17BETA-OL-20-YN-3-ONE;4,17a-pregnen-17b-ol-20-yn-3-one;4,17A-PREGNEN-17B-OL-20-YNE;4-ANDROSTEN-17-ALPHA-ETHYNYL-17-BETA-OL-3-ONE;(8R,9S,10R,13S,14S,17R)-17-ETHYNYL-17-HYDROXY-10,13-DIMETHYL-1,2,6,7,8,9,10,11,12,13,14,15,16,17-TETRADECAHYDRO-CYCLOPENTA[A]PHENANTHREN-3-ONE;ANHYDROHYDROXYPROGESTERONE;ANHYDROXYPROGESTERONE;17BETA-HYDROXY-4,17ALPHA-PREGNEN-20-YN-3-ONE
  
  CAS NO.: 434-03-7
  
  Assay: 98%
  
  Molecular Formula:C21H28O2
  
  Molecular Weight:312.45
  
  Packing:1kg / foil bags
  
  Appearance: White or milky white crystalline powder. Melting point 269-275 ℃, at 190-195 ℃ in high vacuum sublimation. Slightly soluble in ethanol, acetone, chloroform and vegetable oils, in fact, insoluble in water
  
  Usage:Similar to the yellow like progesterone, for the treatment of excessive menstrual bleeding, or sub-camps can also be used to prevent threatened abortion and habitual abortion. Progesterone is a progestin by the corpus luteum and the placenta secreted is more than the synthetic

• CAS Registry Number:

  434-03-7

• Synonyms:

  ;Ethisterone,98%;17-alpha-ethynyltestosterone;pregneninolone;17a-ethynyl-17b-hydroxy-4-androsten-3-one;17a-ethynyl testosterone;anhydrohydroxyprogesterone;ethynyl testosterone;Gestoral;17-hydroxypregn-4-en-20-yn-3-one;(8xi,9xi,10xi,13xi,14xi,17alpha)-17-hydroxypregn-4-en-20-yn-3-one;(8xi,9xi,14xi,17alpha)-17-hydroxypregn-4-en-20-yn-3-one;(17alpha)-17-hydroxypregn-4-en-20-yn-3-one;

• Molecular Formula:

  C₂₁H₂₈O₂

• Molecular Weight:

  312.4458

• Molecular Structure:

  

• Hazard Symbols:

   Xn:Harmful;
  

• Risk Codes:

  R40:;
  R48:;
  

• Safety Description:

  S22:;
  S24/25:;
  

• Company:

  Hongkong Saichuang tech.co.ltd     [ China ]        

• Contact:

  Sun Shun

• Tel:

  +86-027-88215630

• Fax:

• Email:

  smith@ycphar.com